Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.

Antimicrobial agents and chemotherapy - 1 Feb 1990

Jones R N, Barry A L

Abstract excerpt

WIN 57273 is a new fluoroquinolone that has an expanded spectrum of activity against Staphylococcus spp. (MIC for 90% of isolates [MIC90], 0.008 microgram/ml), Enterococcus faecalis (MIC90, 0.06 microgram/ml), Bacillus spp. (MIC90, 0.03 micrograms/ml), Listeria monocytogenes (MIC90, 0.06 microgram/ml), Streptococcus spp. (MIC90, 0.03 microgram/ml), and Bacteroides fragilis group strains (MIC90, 0.5 microgram/ml)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Bacteria
Share to Culture Media

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Fluoroquinolones

Share to Hydrogen-Ion Concentration

Share to Microbial Sensitivity Tests

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 2327779
DOI: 10.1128/AAC.34.2.306
PMCID: PMC171578

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.PMID 2327779Read ↗

WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.Semantic proximity Read ↗

In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.Semantic proximity Read ↗

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone.Semantic proximity Read ↗

In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.Semantic proximity Read ↗

Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants.Semantic proximity Read ↗

Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci.Semantic proximity Read ↗

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agentsSemantic proximity Read ↗

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.Semantic proximity Read ↗

In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex IsolatesSemantic proximity Read ↗

In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates.Semantic proximity Read ↗

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.Semantic proximity Read ↗

In Vitro and In Vivo Antibacterial Activities of DC-159a, a New FluoroquinoloneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.